Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Resident & Fellow Section

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
American Academy of Neurology Journals
Home
  • Subscribe
  • My Alerts
  • Log in
Site Logo

Topics A-Z

  • Aducanumab & Alzheimer disease
  • Autonomic diseases
  • Bioterrorism
  • CBMRT/Null Hypothesis
  • Cerebrovascular disease/Stroke
  • Clinical Neurology
  • Clinical Neurophysiology
  • Clinical Trials
  • Cognitive Disorders/Dementia
  • COVID-19
  • Dementia with Lewy Bodies
  • Demyelinating disease (CNS)
  • Education
  • Epidemiology
  • Epilepsy/Seizures
  • Ethics in Neurology/Legal issues
  • Gender
  • Genetics
  • Global Neurology
  • Headache
  • Health Services Research
  • History of Neurology
  • Inclusion, Diversity, Equity,
    Anti-racism, & Social Justice
  • Imaging
  • Immunology
  • Infections
  • Level of Evidence Classification - Class I
  • Level of Evidence Classification - Class II
  • Level of Evidence Classification - Class III
  • Level of Evidence Classification - Class IV
  • Medical/Systemic Disease
  • Migraine
  • Movement Disorders
  • Neuro-ophthalmology
  • Neuroendocrinology
  • Neuromuscular Disease
  • Neuropsychology/Behavior
  • Neurotology
  • Oncology
  • Pain
  • Palliative Care
  • Parkinson disease/Parkinsonism
  • Pediatric
  • Practice Management
  • Psychiatric Disorders
  • Rehabilitation
  • Sleep Disorders
  • Spinal Cord
  • Toxicology
  • Trauma
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Advertisement
Site Logo
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise